Chemical synthesis of Haemophilus influenzae glycopeptide conjugates
- PMID: 9076509
- DOI: 10.1023/a:1018500712733
Chemical synthesis of Haemophilus influenzae glycopeptide conjugates
Abstract
A simple procedure for conjugating synthetic fragments of the capsular polysaccharide of Haemophilus influenzae type b, poly-3-beta-D-ribose-(1,1)-D-ribitol-5-phosphate (sPRP) to linear peptides is described. The procedure consists of (i) reacting the amino group of amino-heptyl sPRP with m-maleimidobenzoyl-N-hydroxysuccinimide (MBS) in phosphate buffer, pH 7.5; (ii) selectively coupling the MBS-modified sPRP to the sulfhydryl group of the cysteine residue of peptides containing functional T-helper cell epitope(s). The glycopeptide conjugates were purified by gel filtration chromatography, biochemically characterized, and elicited protective level of anti-PRP antibody responses in rabbits.
Similar articles
-
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines.Infect Immun. 1997 Dec;65(12):4918-25. doi: 10.1128/iai.65.12.4918-4925.1997. Infect Immun. 1997. PMID: 9393776 Free PMC article.
-
Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease.J Infect Dis. 1992 Jun;165 Suppl 1:S152-5. doi: 10.1093/infdis/165-supplement_1-s152. J Infect Dis. 1992. PMID: 1588151
-
Mapping of antigenic and immunogenic sites of Haemophilus influenzae outer membrane protein P6 using synthetic lipopeptides.Biol Chem Hoppe Seyler. 1994 Mar;375(3):173-82. doi: 10.1515/bchm3.1994.375.3.173. Biol Chem Hoppe Seyler. 1994. PMID: 7516662
-
Vaccine development: progression from target antigen to product.Adv Exp Med Biol. 1992;327:263-71. doi: 10.1007/978-1-4615-3410-5_28. Adv Exp Med Biol. 1992. PMID: 1295345 Review. No abstract available.
-
Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.Pediatrics. 1990 Apr;85(4 Pt 2):698-704. Pediatrics. 1990. PMID: 2107522 Review.
Cited by
-
Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases.Russ J Bioorg Chem. 2021;47(1):26-52. doi: 10.1134/S1068162021010106. Epub 2021 Mar 20. Russ J Bioorg Chem. 2021. PMID: 33776394 Free PMC article.
-
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines.Infect Immun. 1997 Dec;65(12):4918-25. doi: 10.1128/iai.65.12.4918-4925.1997. Infect Immun. 1997. PMID: 9393776 Free PMC article.
-
A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.Nanomedicine. 2015 Feb;11(2):447-56. doi: 10.1016/j.nano.2014.08.005. Epub 2014 Sep 3. Nanomedicine. 2015. PMID: 25194998 Free PMC article.
-
Synthesis and Immunogenicity of Pseudo-Oligosaccharides Structurally Related to Repeating Units of Capsular Phosphoglycans of Human Pathogens.Molecules. 2025 Jul 22;30(15):3068. doi: 10.3390/molecules30153068. Molecules. 2025. PMID: 40807243 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials